Has anyone of you been to an emerging market? I have. And the way pharma works there is very different from the US. Forget what you learnd in the US, about new products brining profits. In the emerging markets people don't care about expensive new products, they don't have enough basics. They need a lot of basics at cheap price.
Second, these markets are very unregulated, allowing for higher profit margins.
Third, the markets are huge and allow for many companies to succeed.
This one will be a winner.
However, many emerging market stocks tend to underperform initially because people in the US don't realize how different these markets are and that things that work in the US don't necessarily work there and vice versa.